Cardlytics, Inc. (CDLX) stock: key figures, P/E, revenue and dividend
Information Technology · United States · ISIN US14161W1053
Cardlytics, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 233.27 m USD |
| Operating income | -101.82 m USD |
| EBIT | -116.79 m USD |
| Net income | -103.49 m USD |
| Diluted EPS – continuing operations | -1.95 USD |
Full history since 2015, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Cardlytics, Inc.
Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. The company provides Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data from merchant data partners, including product-level purchase data to enable marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing. Cardlytics, Inc. was incorporated in 2008 and is headquartered in Atlanta, Georgia.
More stocks
- Upland Software, Inc. (UPLD)
- CalciMedica, Inc. (CALC)
- Vistagen Therapeutics, Inc. (VTGN)
- Summit Networks Inc. (SNTW)
- INTRUSION INC (INTZ)
- Reborn Coffee, Inc. (REBN)
- VPR Brands, LP. (VPRB)
- Ensysce Biosciences, Inc. (ENSC)
- Crown Equity Holdings, Inc. (CRWE)
- Rocket One Inc. (RKTO)
- Adaptimmune Therapeutics PLC (ADAPY)
- iQSTEL Inc (IQST)
Not investment advice. All data without warranty, price as of 12.11.2026. Details in the risk notice.